5:26 PM ET
8-K
M&A Deal
Axogen M&A Deal with BioCircuit Technologies, Inc.
Axogen, Inc. has completed its acquisition of BioCircuit Technologies, Inc., a developer of NerveTape™, the first FDA-cleared sutureless device for peripheral nerve repair. The acquisition is expected to contribute approximately $34 million to Axogen's 2027 revenue and aligns with the company's mission to restore peripheral nerve function.
- Counterparty
- BioCircuit Technologies, Inc.